Alzheimer's Disease Clinical Trials in New York

Showing 21-40 of 291 trials

Developing a Communication Intervention for People With Memory Challenges and Their Care Partners

NCT05143255

The proposed research is consistent with broader public health goals focused on improving communication regarding end-of-life care and the Centers for Medicare and Medicaid Services' (CMS) call for increased patient engagement in advance care planning (ACP) as part of standard care. The proposed study will address this public health issue by developing a communication-based intervention designed to improve Alzheimer's Disease and Related Dementias (ADRD) patients' and care partners' engagement in ACP, distress and care partner burden, and completion of advance directives and receipt of goal-concordant care at the end-of-life. Therefore, this study is aligned with the National Institute on Aging's long-term goal to improve the quality of care for ADRD patients and CMS's goal to increase engagement in ACP.

Alzheimer DiseaseDementia

Weill Medical College of Cornell University38 participantsStarted Dec 2024

New York, New York, United States

RECRUITINGPhase 3< 1 mile

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

NCT07177352

This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.

Alzheimers Disease

Hoffmann-La Roche13,000 participantsStarted Jul 2025

Phoenix, Arizona, United States • Sun City, Arizona, United States • Imperial, California, United States +204 more locations

Developing a Communication Intervention for People With Memory Challenges and Their Care Partners

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Alzheimer's Disease Trials in Other Cities

A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's Disease

Couples Lived Experience

Longitudinal Early-onset Alzheimer's Disease Study Protocol

Investigating the Impact of Duration and Amount of Light on the Circadian System Response - Aim 3

A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Study of the Aliviado DSD Caregiving Mastery Program

Music Therapy Experiences in Patients With Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)

ACP-204 in Adults With Alzheimer's Disease Psychosis

Neurostimulation for Cognitive Enhancement in Alzheimer's Disease

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

Palliative Care Educator

Pilot Testing Dementia-Enhanced Training and Tool for Home Hospice Clinicians

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001

A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes

Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease

[18F]PI-2620 Phase 3 Histopathological Study

A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease

Other Conditions in New York